| 000 | 01892 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517190329.0 | ||
| 264 | 0 | _c20180717 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a2213-6711 | ||
| 024 | 7 |
_a10.1016/j.stemcr.2017.10.028 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMa, Yufang | |
| 245 | 0 | 0 |
_aInhibition of Farnesyltransferase Potentiates NOTCH-Targeted Therapy against Glioblastoma Stem Cells. _h[electronic resource] |
| 260 |
_bStem cell reports _c12 2017 |
||
| 300 |
_a1948-1960 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmyloid Precursor Protein Secretases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Self Renewal _xdrug effects |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aFarnesyltranstransferase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 |
_aGlioblastoma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aNeoplastic Stem Cells _xdrug effects |
| 650 | 0 | 4 |
_aRadiation Tolerance _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Notch _xantagonists & inhibitors |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aCheng, Zhixiang | |
| 700 | 1 | _aLiu, Jing | |
| 700 | 1 | _aTorre-Healy, Luke | |
| 700 | 1 | _aLathia, Justin D | |
| 700 | 1 | _aNakano, Ichiro | |
| 700 | 1 | _aGuo, Yan | |
| 700 | 1 | _aThompson, Reid C | |
| 700 | 1 | _aFreeman, Michael L | |
| 700 | 1 | _aWang, Jialiang | |
| 773 | 0 |
_tStem cell reports _gvol. 9 _gno. 6 _gp. 1948-1960 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.stemcr.2017.10.028 _zAvailable from publisher's website |
| 999 |
_c27848075 _d27848075 |
||